Leslie A. Royds Draper

Array ( [id] => 11303111 [patent_doc_number] => RE046228 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2016-12-06 [patent_title] => 'Pigmentation-regulating compounds' [patent_app_type] => reissue [patent_app_number] => 14/175312 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10472 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511955 [patent_doc_number] => 20140148447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'AGENT FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF HERPES INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/167676 [patent_app_country] => US [patent_app_date] => 2014-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1091 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14167676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10450647 [patent_doc_number] => 20150335662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'METHODS FOR DIAGNOSING AND TREATING SEPSIS' [patent_app_type] => utility [patent_app_number] => 14/761939 [patent_app_country] => US [patent_app_date] => 2014-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15463 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799701 [patent_doc_number] => 20150011646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'USAGE OF GUTTIFERONE K, A NATURAL COMPOUND FROM GARCINIA YUNNANENSIS HU ON TREATING HIGH METASTATIC ESOPHAGEAL CANCER' [patent_app_type] => utility [patent_app_number] => 14/149821 [patent_app_country] => US [patent_app_date] => 2014-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2076 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14149821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435073 [patent_doc_number] => 20140112980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'ABUSE-RESISTANT PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/139046 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10457 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774731 [patent_doc_number] => 20160120887 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-05-05 [patent_title] => 'TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE' [patent_app_type] => utility [patent_app_number] => 14/106292 [patent_app_country] => US [patent_app_date] => 2013-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12465 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14106292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10774731 [patent_doc_number] => 20160120887 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-05-05 [patent_title] => 'TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE' [patent_app_type] => utility [patent_app_number] => 14/106292 [patent_app_country] => US [patent_app_date] => 2013-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12465 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14106292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10421045 [patent_doc_number] => 20150306056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'USE OF A DHA ESTER FOR PROPHYLACTIC AND/OR CURATIVE TREATMENT OF DREPANOCYTOSIS' [patent_app_type] => utility [patent_app_number] => 14/647364 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5861 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13026301 [patent_doc_number] => 10035766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => Compositions for preventing and/or treating lysosomal storage disorders [patent_app_type] => utility [patent_app_number] => 14/083634 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11607 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10128105 [patent_doc_number] => 09161926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-20 [patent_title] => 'Topical dapsone and dapsone/adaplene compositions and methods for use thereof' [patent_app_type] => utility [patent_app_number] => 14/082955 [patent_app_country] => US [patent_app_date] => 2013-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5674 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14082955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10467048 [patent_doc_number] => 20150352063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'Drug for Killing Acid-Fast (Red) Bacillus' [patent_app_type] => utility [patent_app_number] => 14/760458 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6283 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361060 [patent_doc_number] => 20150246065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'Topical Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 14/427906 [patent_app_country] => US [patent_app_date] => 2013-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7318 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491711 [patent_doc_number] => 20140142117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'REVERSE AMIDE COMPOUNDS AS PROTEIN DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/076596 [patent_app_country] => US [patent_app_date] => 2013-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24259 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14076596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9597710 [patent_doc_number] => 20140194391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'CALCIUM/SODIUM SALT OF INOSITOL TRIPYROPHOSPHATE AS AN ALLOSTERIC EFFECTOR OF HEMOGLOBIN' [patent_app_type] => utility [patent_app_number] => 14/075878 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11926 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339676 [patent_doc_number] => 20140066458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'METHODS FOR TREATING VASCULAR LEAK SYNDROME' [patent_app_type] => utility [patent_app_number] => 14/075809 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 56963 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9643288 [patent_doc_number] => 20140221400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSYEM ATROPHY (MSA) 938' [patent_app_type] => utility [patent_app_number] => 14/075790 [patent_app_country] => US [patent_app_date] => 2013-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9477821 [patent_doc_number] => 20140135284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'COMPOSITION OF AQUEOUS BUFFER SOLUTION FOR THE TREATMENT OF CELLULAR ENVIRONMENT AND ION CHANNELS AND METHODS FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 14/073153 [patent_app_country] => US [patent_app_date] => 2013-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3078 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428910 [patent_doc_number] => 20150313921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'Cancer Treatment Methods' [patent_app_type] => utility [patent_app_number] => 14/439471 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6210 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353497 [patent_doc_number] => 20150238502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'Compositions and Methods for Treating Stroke' [patent_app_type] => utility [patent_app_number] => 14/433172 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6020 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307123 [patent_doc_number] => 20140045797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'Bisphosphonate-Prostatic Acid Phosphatase Inhibitor Conjugates To Treat Prostate Cancer Bone Metastasis' [patent_app_type] => utility [patent_app_number] => 14/055313 [patent_app_country] => US [patent_app_date] => 2013-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6924 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14055313 [rel_patent_id] =>[rel_patent_doc_number] =>)